Product NDC: | 52125-186 |
Proprietary Name: | Ziprasidone |
Non Proprietary Name: | ZIPRASIDONE HYDROCHLORIDE |
Active Ingredient(s): | 20 mg/1 & nbsp; ZIPRASIDONE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52125-186 |
Labeler Name: | REMEDYREPACK INC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020825 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20130104 |
Package NDC: | 52125-186-02 |
Package Description: | 30 CAPSULE in 1 BLISTER PACK (52125-186-02) |
NDC Code | 52125-186-02 |
Proprietary Name | Ziprasidone |
Package Description | 30 CAPSULE in 1 BLISTER PACK (52125-186-02) |
Product NDC | 52125-186 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ZIPRASIDONE HYDROCHLORIDE |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20130104 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | REMEDYREPACK INC. |
Substance Name | ZIPRASIDONE HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Atypical Antipsychotic [EPC],Atypical Antipsychotic [EPC] |